Explore 3 Stock Ideas & Industry Insights Download Free Report
.png)
Business Overview
RSA Insurance Group Plc (LON: RSA) is a British-based general insurer, offering insurance to individuals and businesses ranging from small businesses to large corporations.
Financial Highlights – Financial Year 2019
In 2019, the company delivered a strong result, with underlying earnings per share increased to 44.5 pence (ex. exits) and the total dividend was up by 10%. Net written premiums of £6,417 million were decreased by 1% in the period at constant FX. Underlying premiums reduced by 2% when adjusted for reinsurance changes but broadly flat excluding the exit portfolios. The personal lines businesses have premiums of 57% with a combined ratio of 88.5% for 2019. On 31st December 2019, the Solvency II coverage ratio of 168%, higher than the previous target. Excluding exits, the underlying return on tangible equity of 16%, in the upper part of 13-17% target range.
Share Price Performance
.png)
Daily Chart as on 18thMarch 2020, before the market closed (Source: Thomson Reuters)
On March 18, 2020, at the time of writing (before the market close, at 12:31 PM GMT), RSA Insurance Group Plc shares were trading at GBX 338, down by 8.45 per cent against the previous day closing price. Stock's 52 weeks High and Low are GBX 736.84/GBX 334.60.
From the technical standpoint, 14 days-Relative Strength Index of the stock is hovering near the oversold zone, which is strengthening the upside move.
Valuation Methodology
.png)
Growth Catalyst
The Group focused on driving towards best-in-class capabilities and performance. In Scandinavia, the mid-single-digit rates and robust retention of 85 per cent contributed. Premium growth in most profitable lines such as Sweden up 2% and Johnson up 13%. Johnson continues to demonstrate robust growth, profitability and excellent customer retention. Personal Lines growth in Canada and Sweden, and Commercial Lines growth in Scandinavia.
Conclusion
The company is aiming for further progress in 2020. Based on existing forward bond yields and FX rates, investment income is projected to be in the range of £255-£270 million in 2020, and existing FX rates imply a 2 per cent headwind in pounds terms on operating profits against 2019. The group anticipate Net Written Premiums to be same in 2020 as compared with 2019 at constant FX, and Net Earned Premiums marginally lower reflecting residual earn through of 2019 actions. RSA is witnessing growth in its underwriting profit overall and from each region. The profits are increasing, return on tangible equity is very good, and the dividends are up. This growth is driven by enhanced underwriting. The change in management and growth in the UK & International division are showing good progress. The company focuses on underwriting enhancement with robust cost control which could lead the business of the Group. There are some challenges, but the company are capable enough to tackle them.
Based on the decent prospects which are supported by valuation done using the above method, we have given a “Buy” recommendation at the current price of GBX 336.90 (as on 18th March 2020 at 12:13 PM GMT) with lower double-digit upside potential based 8.45x NTM Price/Earnings Value (approx.) on FY20E earnings per share (approx.).
*All forecasted figures have been taken from Thomson Reuters.
Disclaimer
PLEASE BE ADVISED THAT YOUR CONTINUED USE OF THIS SITE OR THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THESE TERMS.
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine is not responsible for material posted on this website and does not guarantee the content, accuracy, or use of the content in this site. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated.
Kalkine do not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional licensed financial planner and adviser.
Past performance is not a reliable indicator of future performance.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…